Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-28,900
Closed -$3.71M 2994
2021
Q4
$3.71M Buy
28,900
+8,800
+44% +$1.36M 0.01% 1394
2021
Q3
$2.88M Sell
20,100
-20,900
-51% -$2.87M 0.01% 1642
2021
Q2
$4.78M Buy
41,000
+9,000
+28% +$886K 0.01% 1233
2021
Q1
$2.57M Buy
32,000
+24,900
+351% +$1.9M 0.01% 1513
2020
Q4
$445K Sell
7,100
-4,200
-37% -$240K ﹤0.01% 2599
2020
Q3
$483K Sell
11,300
-3,100
-22% -$120K ﹤0.01% 2277
2020
Q2
$530K Buy
14,400
+2,200
+18% +$58.2K ﹤0.01% 1962
2020
Q1
$207K Buy
+12,200
New +$389K ﹤0.01% 2631

Other funds holding CROX

John Overdeck's CROX Position: Q2 2026 in Review

John Overdeck increased its Crocs (CROX) stake by 4.7% in Q2 2026, buying an estimated $286K and bringing the position to 58,867 shares worth $7.1M. The position accounts for 0.01% of the portfolio, ranked #1819.

John Overdeck first reported a position in CROX in Q2 2013 and has held it in 41 quarters since. The position peaked at $157M in Q3 2021. 499 funds tracked by Wall St. Rank hold CROX as of Q2 2026.

  • John Overdeck held 58,867 shares of Crocs worth $7.1M as of Q2 2026.
  • John Overdeck bought 2,620 Crocs shares in Q2 2026, an estimated $286K.
  • Crocs made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1819 holding.
  • John Overdeck first reported a position in Crocs in Q2 2013 and has held it in 41 quarters since.
  • John Overdeck's Crocs position peaked at $157M in Q3 2021.
  • 499 funds tracked by Wall St. Rank held Crocs as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.